EUVIMED · CrossrefZeitschrift
Pharmacology Research & Perspectives
ISSN 2052-1707 · Wiley
Neueste Artikel
Drug Utilization Patterns and WHO Prescribing Indicators Among Hypertensive Outpatients at Karnali Academy of Health Sciences, Nepal: A Cross‐Sectional Study
Characterization of the Lysophosphatidic Acid Receptor 5 Antagonist RLPA ‐76 as a Novel Analgesic in Male Rats and Mice
Industry Perspective on Current Guidelines, Challenges, and Future Directions for ADME Characterization of Payloads for Antibody‐Drug Conjugates
Baricitinib Ameliorates Cutaneous Leukocytoclastic Angiitis in Rats
The JAK1 /2 Inhibitor Baricitinib Ameliorates Neuroinflammation and Symptoms in an Animal Model of Essential Tremor
Investigation of the Effects of Methylphenidate on Hemodynamic Parameters in Children With ADHD
The Use of Statins in Parkinson's and Alzheimer's Disease: A 2021–2025 State‐of‐the‐Art Review of Clinical and Preclinical Evidence
Effect of Interleukin‐6 Inhibitors on Rheumatoid Arthritis Pain: Overview of Evidence and Mechanistic Pathways
Risk of Major Congenital Malformations Associated With the First‐Trimester Exposure to Antipsychotics: A Large Claims Database Study
Psychedelic Therapies for Comorbid Major Depressive Disorder and Chronic Pain: A Review of Putative Mechanisms of Action
Advances in Therapeutic Antibody Discovery and Development Targeting G Protein‐Coupled Receptors
Effect of Thrombopoietin Receptor Agonist Romiplostim on the Ionizing Radiation‐Induced Premature Aging
Team‐Based Learning in the Meta Horizon Workroom: A Pilot Study on Its Potential Effectiveness for Pharmacology Teaching
No Evidence of QTc Interval Prolongation With Baxdrostat Treatment: Concentration–QTc Modeling Assessment
Multi‐Target Drug Design in Alzheimer's Disease Treatment: Emerging Technologies, Advantages, Challenges, and Limitations
Molecular Docking, Dynamics, and Preclinical Studies Reveal Morin Hydrate as a Potent PPARγ and Nrf2 Agonist That Mitigates Colon Inflammation
Insights Into Atorvastatin Pharmacokinetics in Rats Reveal Regulation of CYP3A1 by Humanization of SLCO2B1
Preclinical Evaluation of the Oral Toxicity, Genotoxicity, and Safety Pharmacology of LPM4870108 , a Novel Potent Tropomyosin Receptor Kinase Inhibitor
Recent Advances in the Therapeutic Potential of Cannabinoids Against Gliomas: A Systematic Review (2022–2025)
Risk Management of Medication Errors: Improving the Quality of Pharmacotherapeutic Practice
In Vitro Structure–Activity Relationship Stability Study of Antisense Oligonucleotide Therapeutics Using Biological Matrices and Nucleases
Psilocin, A Psychedelic Drug, Exerts Anticonvulsant Effects Against PTZ‐ and MES‐Induced Seizures in Mice via 5‐HT1A and CB1 Receptors: Involvement of Nitrergic, Opioidergic, and Kynurenine Pathways
The Chicken Embryo: An Alternative Animal Model in Development, Disease and Pharmacological Treatment
An Updated Bio‐Behavioral Profile of the Flinders Sensitive Line Rat: Reviewing the Findings of the Past Decade
BCyrius : An Upgraded Version of Cyrius for Accurate CYP2D6 Genotyping From Short‐Read Sequencing Data
Edaravone is a Therapeutic Candidate for Doxorubicin‐Induced Cardiomyopathy by Activating the Nrf2 Pathway
Obicetrapib exhibits favorable physiochemical and pharmacokinetic properties compared to previous cholesteryl ester transfer protein inhibitors: An integrated summary of results from non‐human primate studies and clinical trials
Evaluating Blood–Brain Barrier Permeability, Cytotoxicity, and Activity of Potential Acetylcholinesterase Inhibitors: In Vitro and In Silico Study
The endocannabinoid system in appetite regulation and treatment of obesity
A dose‐adjusted, open‐label, pilot study of the safety, tolerability, and pharmacokinetics of STC3141 in critically ill patients with sepsis
EUVIMED